Ad Header

PharmaLive

Slogan

The Pulse of the Pharmaceutical Industry

Olympics: IOC discussing norovirus outbreak, more cases reported

Written by: | no-reply@reuters.com | Dated: Thursday, February 8th, 2018

 

Olympics: IOC discussing norovirus outbreak, more cases reported

 

By Peter Rutherford | PYEONGCHANG, SOUTH KOREA

 

Olympic officials are discussing measures to combat the spread of a virus that causes vomiting and diarrhea after 42 new cases were confirmed at the Winter Games, a Korean Centers for Disease Control and Prevention (KCDC) official said on Friday.

After rising from an initial 32 norovirus cases on Tuesday to 54 on Wednesday, the figure had risen to 128 as of late Thursday, with most of those affected security personnel, the KCDC said.

The virus broke out ahead of Friday’s opening ceremony in Pyeongchang and led to some 1,200 security staff being quarantined. Organizers have had to call in military personnel to replace them.

As yet, no athletes have been confirmed to have contracted the highly contagious virus. An outbreak at last year’s World Athletics Championship in London forced competitors from several countries to miss events.

Su Mun-gyo, a KCDC public relations official, told Reuters the International Olympic Committee (IOC) were discussing the issue.

“The IOC is meeting right now about the Winter Olympics and countermeasures to the norovirus is one of the topic,” Su said. “We will then announce the results of the discussions and update the number of cases again.”

Health agencies are undertaking hygiene inspections at accommodation and restaurants, as well as making checks on drinking and tap water.

 

(Writing by Peter Rutherford; Reporting by Yuna Park; Editing by John O’Brien)

 

Reuters source:

https://www.reuters.com/article/us-olympics-2018-virus/olympics-ioc-discussing-norovirus-outbreak-more-cases-reported-idUSKBN1FT07C?il=0

Ad Right Top

MedAdNews

Extensive pharmaceutical business and marketing intelligence. For back issues, please contact MDAD@kmpsgroup.com.

August 2018 Focus: Top 200 Meds, Year After Launch, VR/AR and more!

Subscribe

Ad Right Bottom